|Previous Section||Index||Home Page|
Mr. Jeremy Browne: To ask the Secretary of State for Health what mandatory training is required of (a) intensive care and (b) accident and emergency medical staff on (i) obtaining consent for organ donation and (ii) organ donation procedures; and if he will make a statement. 
Ann Keen: The Department does not collect this information centrally. We have commissioned the Central Office of Information to map the existing training provision, validate the training requirement gap and identify solutions for priority audiences.
This work was commissioned in response to the recommendation in Organs for Transplants, by the Organ Donation Taskforce, that all clinical staff likely to be involved in the treatment of potential organ donors should receive mandatory training in the principles of organ donation.
Once this piece of work is completed, the Department will be working with the national health service, NHS Blood and Transplant (NHSBT) and other key stakeholder organisations to ensure that NHS performance in these areas improves.
Phil Hope: From December 2007 to November 2008 Prescription Cost Analysis (PCA) data collected by NHS Prescription Services, indicate that 630,800 prescription items for Buprenorphine products, of which Subutex is a brand, were dispensed by community pharmacists in England. PCA data records what has been reimbursed to dispensing contractors but does not record which particular Buprenorphine products have been dispensed to fill generically written prescriptions. Therefore the data also includes generically written prescriptions for Buprenorphine which may have been dispensed with Subutex.
Phil Hope: The current guidelines were updated in 2007 and are set out in Drug Misuse and Dependence: UK Guidelines on clinical management. Additional guidance is contained in Clinical management of drug dependence in the adult prison setting, including psychosocial treatment as a core part published in 2006. Copies of both documents have already been placed in the Library.
John Smith: To ask the Secretary of State for Health what plans he has to include risk assessment for venous thromboembolism in hospitalised patients as an indicator in the Commissioning for Quality and Innovation payment framework. 
Mr. Bradshaw: The Department is not mandating any indicators for inclusion in the Commissioning for Quality and Innovation (CQUIN) payment framework. The Department has set a framework for schemes to be developed locally, with all indicators and goals to be agreed between health care commissioners and providers. The only requirement is that each local scheme should include at least one goal in each of four areas: safety, effectiveness, patient experience and innovation.
The Department regards the prevention of venous thromboembolism (VTE) in hospitals as an extremely important issue, which is why we published the National VTE Risk Assessment in September 2008, a copy of which has been placed in the Library. The National Institute for Health and Clinical Excellence is also developing a clinical guideline to cover the prevention of VTE in all hospitalised patients, and I understand that they plan to publish the guideline in November of this year.
Mr. Jeremy Browne: To ask the Secretary of State for Health how many people received a (a) heart, (b) lung, (c) kidney, (d) cornea, (e) tissue, (f) pancreas and (g) liver transplant in England in each year since 2000. 
Ann Keen: The following table shows the number of people receiving heart; lung; kidney; cornea; sclera; pancreas and liver transplants in England in each calendar year, 2000 to 2008. Information on other tissues are not held centrally.
1. Figures include all combinations of organs, so for example kidney figures include kidney/pancreas; pancreas figures include pancreas/kidney; kidney figures include kidney/liver etc.
2. Figures include transplants from living donors.
Mr. Jeremy Browne: To ask the Secretary of State for Health what the average post-operation life expectancy of a patient receiving a (a) heart, (b) lung, (c) kidney, (d) liver (e) cornea, (f) pancreas and (g) tissue transplant is. 
Ann Keen: The success of organ transplantation is measured in terms of patient or graft survival rates, rather than life expectancy. With the exception of information on corneas which shows graft survival, the following table illustrates the most recent figures available for adult patient survival one year post transplant in England.
|Transplant type||Survival (percentage)||Year of transplant|
(2 )Graft survival only for corneas.
Ann Keen: Information on the number of donor transplant coordinators employed by national health service trusts is not collected centrally. However as part of the implementation of the Organ Donation Taskforce recommendations, all donor transplant coordinators will eventually be employed by NHS Blood and Transplant. 30 donor transplant coordinators previously employed by NHS trusts, Transfer of Undertakings Protection of Employment (TUPE) transferred to NHSBT employment in October and November 2008. A further 10 TUPE transfers are planned by the end of the current financial year. The TUPE transfer process of the staff within the remaining 12 donor transplant coordinator teams currently employed locally by NHS trusts will take place during the course of 2009-10.
Following two recruitment campaigns, 39 new donor transplant coordinators have been recruited and a third recruitment campaign has been launched with the intention of recruiting a further 20 new staff. Further recruitment campaigns will take place over the next 18 months. It is anticipated that a total of 265 staff, including both donor transplant coordinators and office support staff, will be in post by the end of 2010-11.
Mr. Stephen O'Brien: To ask the Secretary of State for Health pursuant to the answer of 14 January 2009, Official Report, columns 827-32W, on transplant surgery: foreigners, what the (a) NHS tariff and (b) private tariff is in each hospital for each type of transplant. 
Ann Keen: This information is not held centrally. There is no national mandatory tariff for transplant surgery, which means that price for this activity will be subject to negotiation between providers and commissioners.
Mr. Oaten: To ask the Secretary of State for Health whether his Department has issued guidance to local healthcare trusts on minimum arrangements for pre-hospital airway management care of trauma patients. 
Mr. Bradshaw: Ambulance staff are trained and provide airway management care of trauma patients in line with specific clinical guidelines. These are produced by the Joint Royal Colleges Ambulance Liaison Committee.
Mr. Philip Hammond: To ask the Minister for Women and Equality how many equalities impact assessments the Government Equalities Office has undertaken in the last 12 month period for which figures are available; and what estimate she has made of the cost to the public purse of such assessments. 
Maria Eagle: The Government Equalities Office has not undertaken any impact assessments in the last 12 months. An equality impact assessment for the consultation on the Equality Bill was made in the summer of 2007 and the Government Equalities Office will undertake an assessment on the Bill itself.
Mr. Tyrie: To ask the Minister for Women and Equality what expert advisers have been commissioned by the Government Equalities Office since its establishment; on what topic each was commissioned; and whether the adviser so appointed made a declaration of political activity in each case. 
Mrs. May: To ask the Minister for Women and Equality how many bonuses were awarded to senior civil servants working in the Government Equalities Office in each year since its inception; and what was spent on such bonuses. 
Maria Eagle: The Government Equalities Office currently employs seven senior civil servants. Three of these staff were awarded non-consolidated performance pay totalling £24,000 in 2007-08, the first full year of GEO operations. Given these small numbers information about the individuals involved and the amounts awarded to each cannot be disclosed on grounds of confidentiality.
Mrs. Spelman: To ask the Minister for Women and Equality what (a) research and (b) other work the Equality and Human Rights Commission has undertaken in relation to Travellers in the last 12 months. 
(i) A review of the inequalities experienced by Gypsy and Traveller communities.
(ii) An assessment of local housing authorities progress in meeting the accommodation needs of Gypsy and Traveller communities in England.
(i) The Commissions Policy Position Statement will be issued in March 2009 alongside the research and best practice case studies.
|Next Section||Index||Home Page|